Phase I–II study of carboplatin, epirubicin and VP-16 plus G-CSF in extensive small cell lung cancer (SCLC)

Authors :: M. Gentile
Ar Bianco
Enzo Veltri
Alessandra Rossi
S. De Placido
G P Ianniello
M. D'Aprile
C. Gridelli
Vittorio Gebbia
V. Lo Russo
Carlo Curcio
S. Palmeri
Source :: Lung Cancer. 11:99
Publication Year :: 1994
Publisher :: Elsevier BV, 1994.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Cancer Research
medicine.medical_specialty
Phase i ii
business.industry
Internal medicine
medicine
Carboplatin/epirubicin
Non small cell
business

Tools